Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry
A completed real-world registry in Brazil evaluating outcomes of the Xience V everolimus-eluting coronary stent system in patients with coro…
-
FDA approval · 2012-11-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc. for an already authorized product.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Exercise Testing to Screen for Unknown Coronary Artery Disease in Diabetic Patients: Does it Contribute to a Risk Reduction in Very High Risk Patients? [Phase 3]
A Phase 3 trial investigates whether exercise testing to screen for unknown coronary artery disease in diabetic patients reduces risk in ver…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression
A completed observational study examining whether late-onset depression is associated with cardiovascular disease, including coronary artery…
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)
This is a post-approval USA Phase 1 study of the XIENCE V Everolimus-eluting coronary stent system; it has completed enrollment and posted r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Direct Renin Inhibition Effects on Atherosclerotic Biomarkers [Phase 4]
A Phase 4 clinical trial evaluated the effects of direct renin inhibition on biomarkers of atherosclerosis in patients with coronary artery …
-
FDA label_change · 2012-11-16FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) filed by Viatris Specialty LLC.
-
FDA approval · 2012-11-15FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
A completed clinical trial evaluated whether concurrent use of low-dose aspirin and a proton pump inhibitor affects the risk of acute myocar…
-
CLINICAL_TRIALS research · 2012-11-14Clinical Trial Update: Readiness for Behavior Change After a Heart Attack [NA]
A completed clinical trial from Henry Ford Health System evaluating readiness for behavior change after a heart attack.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention [NA]
This clinical trial evaluated the effects of acute statin treatment in patients undergoing percutaneous coronary intervention. The study was…
-
CLINICAL_TRIALS research · 2012-11-02Clinical Trial Update: Coronary Artery Disease and Renal Failure Registry
An update on a registry for coronary artery disease and renal failure sponsored by Institut für Klinisch-Kardiovaskuläre Forschung GmbH; the…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery [Phase 2]
Phase 2 clinical trial update examining the effects of magnesium in patients undergoing coronary artery bypass graft surgery; results posted…
-
CLINICAL_TRIALS research · 2012-10-30Clinical Trial Update: Dexmedetomidine's Cardiac and Cognitive Influence on Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery
A clinical trial update examining how dexmedetomidine may affect cardiac function and cognitive outcomes in patients undergoing off-pump cor…
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans? [NA]
This clinical trial update reports on the completion of a study examining whether caffeine intake influences the sensitivity of adenosine-ba…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease [Phase 1]
Phase 1 trial comparing prasugrel versus clopidogrel in very elderly and non-elderly patients with stable coronary artery disease has been c…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions [Phase 4]
Phase 4 trial evaluating the Xience V everolimus-eluting stent in saphenous vein graft lesions has completed.
-
CLINICAL_TRIALS research · 2012-10-26Clinical Trial Update: Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention [NA]
The document reports a clinical trial comparing transradial to transfemoral coronary intervention in patients, focusing on safety and effica…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions [Phase 2]
Phase 2 trial of a cobalt-chromium reservoir-based sirolimus-eluting stent for native coronary artery lesions was terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Coronary MDCTA With Iopamidol Injection 370 [Phase 2]
Phase 2 trial of coronary multidetector CT angiography using Iopamidol 370 completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China
Clinical trial registry update showing completion of the Endeavor Zotarolimus-eluting stent registry in China for coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Screening for Coronary Artery Disease Using Fluoroscopy During Coronary Angiography [Phase 4]
Phase 4 study update evaluating fluoroscopy-assisted screening for coronary artery disease during coronary angiography; the trial status is …
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention [Phase 4]
Phase 4 trial update evaluating whether a coronary stent combined with adjunctive medications reduces ischemic recurrences after percutaneou…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study [Phase 3]
ZEUS is a Phase 3 trial evaluating a zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates for coronary artery disease, and …
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: The RAS, Fibrinolysis and Cardiopulmonary Bypass [Phase 4]
Phase 4 clinical trial update examining the renin-angiotensin system, fibrinolysis, and cardiopulmonary bypass in coronary artery disease; t…